Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income
AI Summary
StalkMHO remains in a Stage 2 corrective consolidation within its broader uptrend. Medium-term bias stays Bullish as price is supported above key SMAs, but short-term timing is Neutral due to a tight range and flat-to-rising EMAs. Patient engagement is advised: defer entry until a pullback into the converged EMA/support zone near 150.50 or a decisive breakout above 152.50.